Login / Signup

K v 1.3-induced hyperpolarization is required for efficient Kaposi's sarcoma-associated herpesvirus lytic replication.

Holli CardenKatherine L HarperTimothy James MottramOliver MannersKatie L AllottMark L DallasDavid J HughesJonathan D LippiatJamel MankouriAdrian Whitehouse
Published in: Science signaling (2024)
Kaposi's sarcoma-associated herpesvirus (KSHV) is an oncogenic herpesvirus that is linked directly to the development of Kaposi's sarcoma. KSHV establishes a latent infection in B cells, which can be reactivated to initiate lytic replication, producing infectious virions. Using pharmacological and genetic silencing approaches, we showed that the voltage-gated K + channel K v 1.3 in B cells enhanced KSHV lytic replication. The KSHV replication and transcription activator (RTA) protein increased the abundance of K v 1.3 and led to enhanced K + channel activity and hyperpolarization of the B cell membrane. Enhanced K v 1.3 activity promoted intracellular Ca 2+ influx, leading to the Ca 2+ -driven nuclear localization of KSHV RTA and host nuclear factor of activated T cells (NFAT) proteins and subsequently increased the expression of NFAT1 target genes. KSHV lytic replication and infectious virion production were inhibited by K v 1.3 blockers or silencing. These findings highlight K v 1.3 as a druggable host factor that is key to the successful completion of KSHV lytic replication.
Keyphrases
  • nuclear factor
  • toll like receptor
  • transcription factor
  • binding protein
  • oxidative stress
  • immune response
  • reactive oxygen species
  • drug induced
  • diabetic rats
  • protein protein